Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bordetella pertussis antigens, primarily pertussis toxin (PT) and agglutinogens, are key virulence factors in whooping cough. PT is an AB5 exotoxin that disrupts immune cell function by ADP-ribosylating Gi proteins, leading to increased cAMP. Agglutinogens are surface proteins that induce antibody production and bacterial agglutination. These antigens are important vaccine components.
Pertussis toxin ADP-ribosylates Gi alpha-subunit, leading to increased cAMP levels and disrupted immune cell function. Agglutinogens induce antibody-mediated agglutination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bordetella pertussis Antigens (Pertussis Toxin & Other Components) (N/A).